Aod-9604 Peptide Therapy in Wisconsin

Aod-9604 Peptide Therapy is offered to Wisconsin residents through Thrivelab telehealth. Whether you're near Madison or elsewhere in WI, the entire process — intake, labs, and shipping — happens online.

To qualify for aod-9604 peptide therapy as a Wisconsin resident, you'll verify you're 18+, complete an online intake with a clinician licensed in WI, and finish any required lab work near Madison.

1. Free symptom assessment. 2. Telehealth intake with a Wisconsin-licensed clinician. 3. Labs at any local Quest or Labcorp in Wisconsin. 4. Plan shipped to your Wisconsin address if it's medically appropriate. 5. Ongoing dose review and a dedicated patient-care coordinator.

For Wisconsin patients, the nearest hormone or telehealth clinic can be hours away. Thrivelab brings aod-9604 peptide therapy to you, from Madison to the most rural parts of WI.

Wisconsin patients get transparent pricing confirmed at the free-assessment stage — no surprise fees. Thrivelab works with several US insurers that may offset your cost.

Treatment is provided through Jonathan Larson MDPC. Prescriptions require a clinical evaluation; medication is dispensed only when deemed medically necessary. Information here is educational and not a substitute for medical advice.

Do I need an in-person visit in Wisconsin?

No. The evaluation, plan, and follow-up happen online. Any required labs are completed at a local Quest or Labcorp near Madison.

What if I move out of Wisconsin during aod-9604 peptide therapy?

Tell your patient-care coordinator. Continuation depends on whether Thrivelab clinicians are licensed in your new state.

Is aod-9604 peptide therapy available in Wisconsin?

Yes. Aod-9604 Peptide Therapy is available to Wisconsin residents via telehealth, provided by WI-licensed clinicians under the Jonathan Larson MDPC provider group.

How do I start aod-9604 peptide therapy in Wisconsin?

Take the free assessment, then complete a telehealth intake with a Wisconsin-licensed clinician. They confirm eligibility and next steps.